CGMP-specific phosphodiesterase type 5 - PDFSEARCH.IO - Document Search Engine

CGMP-specific phosphodiesterase type 5
Results: 69

#	Item
21	Tadalafil (Adcirca®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS TADALAFIL? Add to Reading List Source URL: www.phassociation.org Language: English - Date: 2013-12-03 14:16:11 Lactams PDE5 inhibitors Tadalafil Human sexuality CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Erectile dysfunction Phosphodiesterase inhibitor High altitude pulmonary edema Eli Lilly and Company Chemistry Organic chemistry
22	Sildenafil (Revatio®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS SILDENAFIL? Add to Reading List Source URL: www.phassociation.org Language: English - Date: 2013-12-03 14:16:11 PDE5 inhibitors Piperazines Citrates Pyrazolopyrimidines Sildenafil CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Erectile dysfunction Nitric oxide Chemistry Organic chemistry Lactams
23	The score is 26 to 0. There are actually 41 drugs marketed for male sexual dysfunction if you include generics. Even the Score only counts those drugs that have been uniquely approved as new drugs by the FDA and marketed Add to Reading List Source URL: eventhescore.org Language: English - Date: 2014-10-01 17:52:58 PDE5 inhibitors Lactams Piperazines Phenols Testosterone CGMP-specific phosphodiesterase type 5 Erectile dysfunction Tadalafil Sexual dysfunction Chemistry Organic chemistry Human sexuality
24	Microsoft Word - CMDh-PhVWP-002-2009_Rev0_Feb09 Add to Reading List Source URL: www.hma.eu Language: English - Date: 2009-10-30 07:45:33 Lactams Piperazines Pyrazolopyrimidines CGMP-specific phosphodiesterase type 5 Sildenafil Tadalafil Vardenafil Erectile dysfunction Phosphodiesterase PDE5 inhibitors Organic chemistry Chemistry
25	Management of ED (Erectile Dysfunction) Expectations: It will NEVER be as good as it was when you were young. The BEST that can be hoped for is that it will be almost as good as it was before you lost the ability to achi Add to Reading List Source URL: www.nellis.af.mil Language: English - Date: 2014-07-11 17:41:12 Lactams PDE5 inhibitors Sexual health Penis Sexual arousal Priapism Erectile dysfunction Tadalafil CGMP-specific phosphodiesterase type 5 Medicine Human sexuality Organic chemistry
26	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVATIO safely and effectively. See full prescribing information for REVATIO. • Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-11-26 15:04:41 PDE5 inhibitors Piperazines Pfizer Pyrazolopyrimidines Sildenafil CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Sitaxentan Statin Chemistry Organic chemistry Lactams
27	EMA[removed]EMEA/H/C[removed]EPAR summary for the public Spedra Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:43:29 Sexual arousal Sexology Penis Erectile dysfunction Non-sexuality Erection CGMP-specific phosphodiesterase type 5 Placebo Prostate cancer Medicine Human sexuality Human behavior
28	10 WKU Scholar \| Academic Year[removed] Sharron Francis: Add to Reading List Source URL: www.wku.edu Language: English - Date: 2012-10-29 16:12:27 PDE5 inhibitors Piperazines Molecular biology Erectile dysfunction Non-sexuality Sildenafil Tadalafil Cyclic guanosine monophosphate CGMP-specific phosphodiesterase type 5 Chemistry Organic chemistry Lactams
29	Phosphodiesterase 4D is required for ␤2 adrenoceptor subtype-specific signaling in cardiac myocytes Yang Xiang†, Fabio Naro†‡§, Maria Zoudilova‡, S.-L. Catherine Jin‡, Marco Conti‡¶, and Brian Kobilka¶ Add to Reading List Source URL: med.stanford.edu Language: English - Date: 2009-12-04 19:10:48 Phosphodiesterase inhibitor Amrinone CGMP-specific phosphodiesterase type 5 Phosphodiesterase Phospholamban Rolipram Heart failure Myocyte CAMP-dependent pathway Biology Phosphodiesterase-4 inhibitor Pyridines
30	Phosphodiesterase Type 5 Inhibition with Tadalafil CHanges Outcomes in Heart Failure (PITCH-HF) CCC Principal Investigator: Marc J. Semigran, MD Massachusetts General Hospital, New England Research Institutes, NHLBI Bac Add to Reading List Source URL: www.hfsa.org Language: English - Date: 2013-10-12 15:48:10 Chemistry Anatomy Eli Lilly and Company Hypertension Heart diseases Tadalafil Sildenafil CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Lactams PDE5 inhibitors Organic chemistry

UPDATE